ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Crescita Therapeutics Inc

Crescita Therapeutics Inc (CTX)

0,55
-0,03
(-5,17%)
Geschlossen 23 Dezember 10:12PM

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
0,55
Gebot
0,55
Fragen
0,62
Volumen
1.553
0,55 Tagesbereich 0,55
0,36 52-Wochen-Bereich 0,69
Marktkapitalisierung
Handelsende
0,58
Handelsbeginn
0,55
Letzte Trade
53
@
0.55
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
17.690
Ausgegebene Aktien
19.955.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-5,83
Gewinn pro Aktie (EPS)
-0,1
Erlöse
17,52M
Nettogewinn
-1,99M

Über Crescita Therapeutics Inc

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Mississauga, Ontario, Can
Gegründet
-
Crescita Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the Toronto Börse with ticker CTX. The last closing price for Crescita Therapeutics was $0,58. Over the last year, Crescita Therapeutics shares have traded in a share price range of $ 0,36 to $ 0,69.

Crescita Therapeutics currently has 19.955.000 shares in issue. The market capitalisation of Crescita Therapeutics is $11,57 million. Crescita Therapeutics has a price to earnings ratio (PE ratio) of -5.83.

CTX Neueste Nachrichten

Crescita Reports Third Quarter 2024 Results

Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today reported its financial...

Crescita Therapeutics Announces Approval of Normal Course Issuer Bid

Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today announced that the...

Crescita to Present & Participate in 1x1 Meetings at the Planet MicroCap Showcase: VANCOUVER 2024 in Association with Small Cap Discoveries on Thursday, September 26, 2024

Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today announced that it will...

Crescita Reports Second Quarter 2024 Results

Secures Manufacturing Contract of US$10 Million over 4 Years Completes Strategic Asset Acquisition      Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a...

Crescita Secures Contract Manufacturing Revenue of $US10 Million Over 4 Years

Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company with in-house R&D and...

Leading Canadian Healthcare Services Provider Selects Crescita as Exclusive Manufacturing Partner under 5-Year Agreement

Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company with in-house R&D and...

Crescita Expands Medical Aesthetic Portfolio with MicronJetTM600 The World’s Smallest Intradermal Delivery Device

Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today announced that it has...

Crescita Completes Acquisition of Strategic Assets of Occy Laboratory

Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today announced that it has...

Crescita to Acquire Strategic Assets of Occy Laboratory

Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today announced that it has...

Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders

Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today announced the voting...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.01-1.785714285710.560.580.5435580.56034401CS
4-0.07-11.29032258060.620.640.5474850.56960323CS
12-0.05-8.333333333330.60.640.53176900.58595282CS
260.12529.41176470590.4250.690.41191170.5831088CS
520.1537.50.40.690.36167510.52693362CS
156-0.13-19.11764705880.680.830.36156240.59770705CS
260-0.35-38.88888888890.91.010.36195950.66670609CS

CTX - Frequently Asked Questions (FAQ)

What is the current Crescita Therapeutics share price?
The current share price of Crescita Therapeutics is $ 0,55
How many Crescita Therapeutics shares are in issue?
Crescita Therapeutics has 19.955.000 shares in issue
What is the market cap of Crescita Therapeutics?
The market capitalisation of Crescita Therapeutics is CAD 11,57M
What is the 1 year trading range for Crescita Therapeutics share price?
Crescita Therapeutics has traded in the range of $ 0,36 to $ 0,69 during the past year
What is the PE ratio of Crescita Therapeutics?
The price to earnings ratio of Crescita Therapeutics is -5,83
What is the cash to sales ratio of Crescita Therapeutics?
The cash to sales ratio of Crescita Therapeutics is 0,66
What is the reporting currency for Crescita Therapeutics?
Crescita Therapeutics reports financial results in CAD
What is the latest annual turnover for Crescita Therapeutics?
The latest annual turnover of Crescita Therapeutics is CAD 17,52M
What is the latest annual profit for Crescita Therapeutics?
The latest annual profit of Crescita Therapeutics is CAD -1,99M
What is the registered address of Crescita Therapeutics?
The registered address for Crescita Therapeutics is 6733 MISSISSAUGA ROAD, SUITE 800, MISSISSAUGA, ONTARIO, L5N 6J5
What is the Crescita Therapeutics website address?
The website address for Crescita Therapeutics is www.crescitatherapeutics.com
Which industry sector does Crescita Therapeutics operate in?
Crescita Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
APSAptose Biosciences Inc
$ 0,42
(75,00%)
30,28k
RTGRTG Mining Inc
$ 0,04
(60,00%)
3k
BNGBengal Energy Ltd
$ 0,015
(50,00%)
1.000
BBBlackBerry Limited
$ 5,29
(23,60%)
13,59M
ARAAclara Resources Inc
$ 0,495
(17,86%)
27,19k
BABYElse Nutrition Holdings Inc
$ 0,01
(-33,33%)
190k
DIAMStar Diamond Corporation
$ 0,015
(-25,00%)
2,34M
KRNKarnalyte Resources Inc
$ 0,085
(-19,05%)
20,5k
STEPSTEP Energy Services Ltd
$ 4,18
(-14,87%)
283,69k
SBISerabi Gold Plc
$ 2,13
(-11,62%)
73,81k
CNQCanadian Natural Resources Ltd
$ 42,49
(0,02%)
18,71M
TRPTC Energy Corporation
$ 65,77
(0,84%)
17,86M
CMCanadian Imperial Bank of Commerce
$ 92,48
(0,75%)
16,28M
MFCManulife Financial Corporation
$ 43,54
(0,48%)
14,47M
BBBlackBerry Limited
$ 5,29
(23,60%)
13,59M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock